These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Morphological and functional alterations in ventricular myocytes from male transgenic mice with hypertrophic cardiomyopathy. Olsson MC; Palmer BM; Stauffer BL; Leinwand LA; Moore RL Circ Res; 2004 Feb; 94(2):201-7. PubMed ID: 14670849 [TBL] [Abstract][Full Text] [Related]
8. Cardiac dysfunction in hypertrophic cardiomyopathy mutant tropomyosin mice is transgene-dependent, hypertrophy-independent, and improved by beta-blockade. Michele DE; Gomez CA; Hong KE; Westfall MV; Metzger JM Circ Res; 2002 Aug; 91(3):255-62. PubMed ID: 12169652 [TBL] [Abstract][Full Text] [Related]
9. Parvalbumin isoforms differentially accelerate cardiac myocyte relaxation kinetics in an animal model of diastolic dysfunction. Rodenbaugh DW; Wang W; Davis J; Edwards T; Potter JD; Metzger JM Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1705-13. PubMed ID: 17545482 [TBL] [Abstract][Full Text] [Related]
10. Cardiac transgenic and gene transfer strategies converge to support an important role for troponin I in regulating relaxation in cardiac myocytes. Yasuda S; Coutu P; Sadayappan S; Robbins J; Metzger JM Circ Res; 2007 Aug; 101(4):377-86. PubMed ID: 17615373 [TBL] [Abstract][Full Text] [Related]
11. Genetic manipulation of calcium-handling proteins in cardiac myocytes. I. Experimental studies. Coutu P; Metzger JM Am J Physiol Heart Circ Physiol; 2005 Feb; 288(2):H601-12. PubMed ID: 15331372 [TBL] [Abstract][Full Text] [Related]
12. Sphingosine-1-Phosphate Receptor Modulator, FTY720, Improves Diastolic Dysfunction and Partially Reverses Atrial Remodeling in a Tm-E180G Mouse Model Linked to Hypertrophic Cardiomyopathy. Ryba DM; Warren CM; Karam CN; Davis RT; Chowdhury SAK; Alvarez MG; McCann M; Liew CW; Wieczorek DF; Varga P; Solaro RJ; Wolska BM Circ Heart Fail; 2019 Nov; 12(11):e005835. PubMed ID: 31684756 [TBL] [Abstract][Full Text] [Related]
13. Ca2+-independent alterations in diastolic sarcomere length and relaxation kinetics in a mouse model of lipotoxic diabetic cardiomyopathy. Flagg TP; Cazorla O; Remedi MS; Haim TE; Tones MA; Bahinski A; Numann RE; Kovacs A; Schaffer JE; Nichols CG; Nerbonne JM Circ Res; 2009 Jan; 104(1):95-103. PubMed ID: 19023131 [TBL] [Abstract][Full Text] [Related]
14. Optimal range for parvalbumin as relaxing agent in adult cardiac myocytes: gene transfer and mathematical modeling. Coutu P; Metzger JM Biophys J; 2002 May; 82(5):2565-79. PubMed ID: 11964244 [TBL] [Abstract][Full Text] [Related]
15. Parvalbumin: Targeting calcium handling in cardiac diastolic dysfunction. Wang W; Martindale J; Metzger JM Gen Physiol Biophys; 2009; 28 Spec No Focus():F3-6. PubMed ID: 20093724 [TBL] [Abstract][Full Text] [Related]
16. The role of tropomyosin in the regulation of myocardial contraction and relaxation. Wolska BM; Wieczorek DM Pflugers Arch; 2003 Apr; 446(1):1-8. PubMed ID: 12690456 [TBL] [Abstract][Full Text] [Related]
17. Effects of Modified Parvalbumin EF-Hand Motifs on Cardiac Myocyte Contractile Function. Asp ML; Sjaastad FV; Siddiqui JK; Davis JP; Metzger JM Biophys J; 2016 May; 110(9):2094-105. PubMed ID: 27166817 [TBL] [Abstract][Full Text] [Related]
18. NADPH oxidase-derived superoxide impairs calcium transients and contraction in aged murine ventricular myocytes. Rueckschloss U; Villmow M; Klöckner U Exp Gerontol; 2010 Oct; 45(10):788-96. PubMed ID: 20493939 [TBL] [Abstract][Full Text] [Related]
19. A familial hypertrophic cardiomyopathy alpha-tropomyosin mutation causes severe cardiac hypertrophy and death in mice. Prabhakar R; Boivin GP; Grupp IL; Hoit B; Arteaga G; Solaro RJ; Wieczorek DF J Mol Cell Cardiol; 2001 Oct; 33(10):1815-28. PubMed ID: 11603924 [TBL] [Abstract][Full Text] [Related]